Karyopharm Therapeutics
KPTI
KPTI
75 hedge funds and large institutions have $135M invested in Karyopharm Therapeutics in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 31 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
75
Holders Change
-2
Holders Change %
-2.6%
% of All Funds
2%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
11
Increased
31
Reduced
18
Closed
13
Calls
$310K
Puts
$176K
Net Calls
+$134K
Net Calls Change
-$448K
Top Buyers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$1.48M |
| 2 |
NLVP
New Leaf Venture Partners
New York
|
+$1.41M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$857K |
| 4 |
JPMorgan Chase & Co
New York
|
+$549K |
| 5 |
TC
TFS Capital
West Chester,
Pennsylvania
|
+$335K |
Top Sellers
| 1 |
Franklin Resources
San Mateo,
California
|
-$6.75M |
| 2 |
Millennium Management
New York
|
-$3.97M |
| 3 |
GC
Guggenheim Capital
Chicago,
Illinois
|
-$765K |
| 4 |
ARTA
A.R.T. Advisors
New York
|
-$599K |
| 5 |
OPPM
Opus Point Partners Management
New York
|
-$442K |
